Li, J., Cao, S., Xu, J., & Zhong, H. (2019). De novo MET amplification promotes intrinsic resistance to first-generation EGFR tyrosine kinase inhibitors. Cancer Biol Ther.
Style de citation ChicagoLi, Jing-Wen, Shu-Hui Cao, Jian-Lin Xu, et Hua Zhong. "De Novo MET Amplification Promotes Intrinsic Resistance to First-generation EGFR Tyrosine Kinase Inhibitors." Cancer Biol Ther 2019.
Style de citation MLALi, Jing-Wen, Shu-Hui Cao, Jian-Lin Xu, et Hua Zhong. "De Novo MET Amplification Promotes Intrinsic Resistance to First-generation EGFR Tyrosine Kinase Inhibitors." Cancer Biol Ther 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.